73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
GI symptoms persist in older female colorectal cancer survivors, study finds

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba
Study finds use of methotrexate is associated with an increased risk of skin cancer

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal
Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is
COVID vaccination improves effectiveness of cancer treatment, study finds

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi
Study finds younger kidney cancer survivors at significant risk for heart problems

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si
Conspiracy believers more likely to endorse mythical causes of cancer, finds study

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus
Study finds 'startling' inequities in end-of-life opioid treatment

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in
Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

byJohns Hopkins University School of MedicineThis graphic highlights the vast scientific research opportunities associated with neoadjuvant immune checkpoint blockade. Credit:Cancer CellTr

Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

byJohns Hopkins University School of MedicineThis graphic highlights the vast scientific research opportunities associated with neoadjuvant immune checkpoint blockade. Credit:Cancer CellTr
Genomic screening can help detect thyroid cancer, finds study

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET
Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI
Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress
Outpatient stem cell transplants result in less hospitalization time for multiple myeloma patients, study finds

Outpatient stem cell transplants result in less hospitalization time for multiple myeloma patients, study finds

by Leslie Cantu,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainMost multiple myeloma patients undergoing stem cell transplants of their own cells can safely be treated in

Outpatient stem cell transplants result in less hospitalization time for multiple myeloma patients, study finds

by Leslie Cantu,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainMost multiple myeloma patients undergoing stem cell transplants of their own cells can safely be treated in